Rozlytrek

entrectinib · Hoffmann-La Roche

Drug timelines are a Plus or Pro feature.

17 regulatory and trial events tracked for Rozlytrek, covering 2019-08-15 to 2026-07-15. Get the full timeline:

Most recent: EMA Authorised: Rozlytrek (Entrectinib) — Roche Registration GmbH